Neurologiske lidelser Infliximab og andre lægemidler, der hæmmer TNFα, har i sjældne tilfælde været forbundet med optisk neuritis, kramper og indsættelse eller forværring af kliniske symptomer og/ eller radiografiske tegn på demyelinisationsforstyrrelser i centralnervesystemet, inklusive dissemineret sklerose og perifere demyelinisationsforstyrrelser, inklusive Guillain- Barré syndrom.
Neurological events Infliximab and other agents that inhibit TNFα have been associated in rare cases with optic neuritis, seizure and new onset or exacerbation of clinical symptoms and/ or radiographic evidence of central nervous system demyelinating disorders, including multiple sclerosis, and peripheral demyelinating disorders, including Guillain-Barré syndrome.